熱門資訊> 正文
Aspire Bizerma任命新执行主席
2025-07-31 12:49
- Aspire Biopharma (NASDAQ:ASBP) said that Board of Directors has appointed Kraig Higginson as interim CEO, effective July 24, 2025.
- Mr. Higginson serves as Chairman of the Board and previously served as CEO of Aspire for four years.
- Michael C. Howe has resigned as CEO and as a member of the Board.
- The company and plans to initiate a search for a permanent CEO.
More on Aspire Biopharma Holdings, Inc.
- Financial information for Aspire Biopharma Holdings, Inc.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
